Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert J Riley

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|November 10, 2017
Hepatic transporter drug-drug interactions: an evaluation of approaches and methodologiesBeth Williamson, Robert J Riley
Drug Discovery Today. Technologies|July 2, 2014
Metabolic screening in vitro: metabolic stability, CYP inhibition and inductionRobert J Riley, Ken Grime
Drug Discovery Today|September 26, 2015
A new paradigm for navigating compound property related drug attritionPatrick Barton, Robert J Riley
Current Opinion in Drug Discovery & Development|February 26, 2004
Cellular models for ADMET predictions and evaluation of drug-drug interactionsRobert J Riley, J Gerry Kenna
Current Opinion in Chemical Biology|August 4, 2004
Predictive ADMET studies, the challenges and the opportunitiesAndrew M Davis, Robert J Riley
Expert Opinion on Drug Metabolism & Toxicology|February 10, 2015
Cytochrome P450 time-dependent inhibition and induction: advances in assays, risk analysis and modellingRobert J Riley, Claire E Wilson
Expert Opinion on Drug Metabolism & Toxicology|February 3, 2007
Time-dependent CYP inhibitionRobert J Riley, Ken Grime, Richard Weaver
Current Drug Metabolism|January 7, 2011
The use of HepaRG and human hepatocyte data in predicting CYP induction drug-drug interactions via static equation and dynamic mechanistic modelling approachesKen Grime, Douglas D Ferguson, Robert J Riley
Current Drug Metabolism|October 9, 2002
The influence of DMPK as an integrated partner in modern drug discoveryRobert J Riley, Iain J Martin, Anne E Cooper
Journal of Pharmacological and Toxicological Methods|November 7, 2016
Harmonised high throughput microsomal stability assayBeth Williamson, Claire Wilson, Gayle Dagnell, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Expert Opinion on Drug Metabolism & Toxicology|November 10, 2017
Hepatic transporter drug-drug interactions: an evaluation of approaches and methodologiesBeth Williamson, Robert J Riley
Drug Discovery Today. Technologies|July 2, 2014
Metabolic screening in vitro: metabolic stability, CYP inhibition and inductionRobert J Riley, Ken Grime
Drug Discovery Today|September 26, 2015
A new paradigm for navigating compound property related drug attritionPatrick Barton, Robert J Riley
Current Opinion in Drug Discovery & Development|February 26, 2004
Cellular models for ADMET predictions and evaluation of drug-drug interactionsRobert J Riley, J Gerry Kenna
Current Opinion in Chemical Biology|August 4, 2004
Predictive ADMET studies, the challenges and the opportunitiesAndrew M Davis, Robert J Riley
Expert Opinion on Drug Metabolism & Toxicology|February 10, 2015
Cytochrome P450 time-dependent inhibition and induction: advances in assays, risk analysis and modellingRobert J Riley, Claire E Wilson
Expert Opinion on Drug Metabolism & Toxicology|February 3, 2007
Time-dependent CYP inhibitionRobert J Riley, Ken Grime, Richard Weaver
Current Drug Metabolism|January 7, 2011
The use of HepaRG and human hepatocyte data in predicting CYP induction drug-drug interactions via static equation and dynamic mechanistic modelling approachesKen Grime, Douglas D Ferguson, Robert J Riley
Current Drug Metabolism|October 9, 2002
The influence of DMPK as an integrated partner in modern drug discoveryRobert J Riley, Iain J Martin, Anne E Cooper
Journal of Pharmacological and Toxicological Methods|November 7, 2016
Harmonised high throughput microsomal stability assayBeth Williamson, Claire Wilson, Gayle Dagnell, et al.
Pageof 5